创伤性失血性休克后微循环血流动力学变差与内皮细胞损伤及糖萼脱落相关
本研究对17例创伤患者进行舌下入射暗视野视频显微镜检查,在伤后<10小时、10-30小时、30-50小时三个时间点获取微循环血流指数、POEM评分、灌注血管比例、微循环异质性指数、灌注血管密度和总血管密度,并用ELISA检测血栓调节蛋白和syndecan-1作为内皮细胞损伤和糖萼脱落的生物标志物。结果发现伤后10小时内,微循环血流动力学较差(TVD、PVD、PPV、MFI低于均值或MHI高于均值)的患者syndecan-1浓度显著高于17例年龄性别匹配的健康对照,血栓调节蛋白在PPV和MFI较差时也显著升高。作者结论认为内皮细胞损伤和糖萼脱落与创伤性失血性休克后微循环血流、密度和异质性变差相关,但这些生物标志物和血流参数在床旁的临床效用尚未阐明。
要点
- 伤后10小时内,微循环总血管密度较差者syndecan-1为78(IQR 63-417)ng/mL,显著高于健康对照的30(IQR 20-44)ng/mL(p<0.01)。
- 伤后10小时内,灌注血管比例较差者血栓调节蛋白为4.1(IQR 3.4-6.2)ng/mL,显著高于健康对照的2.9(IQR 2.2-3.4)ng/mL(p<0.05)。
- 微循环血流指数较差者syndecan-1为249(IQR 64-578)ng/mL,微循环异质性指数较高者syndecan-1为45(IQR 38-68)ng/mL,均显著高于健康对照(p<0.01)。
- 作者结论认为内皮细胞损伤和糖萼脱落与创伤性失血性休克后微循环血流、密度和异质性变差相关。
- 这些生物标志物和血流参数在床旁的临床效用尚未阐明。
适用人群与场景
- 创伤患者,伤后<10小时、10-30小时、30-50小时三个时间点进行舌下视频显微镜检查。
- 17例创伤患者,中位年龄35岁(IQR 25-52),16/17为男性。
- 对照为17例年龄和性别匹配的健康人。
诊断标准与关键阈值
- 微循环血流动力学较差定义为:微循环血流指数、POEM评分、灌注血管比例、灌注血管密度、总血管密度低于均值,或微循环异质性指数高于均值。
研究设计与关键结果
- 研究类型为预后研究,证据等级III级;共分析17例创伤患者的155个舌下视频显微镜片段,对应39个时间点。
- 伤后10小时内,总血管密度较差者syndecan-1为78(IQR 63-417)ng/mL,灌注血管密度较差者为156(IQR 63-590)ng/mL,灌注血管比例较差者为249(IQR 64-578)ng/mL,微循环血流指数较差者为249(IQR 64-578)ng/mL,微循环异质性指数较高者为45(IQR 38-68)ng/mL,POEM评分较差者为108(IQR 44-462)ng/mL,均显著高于健康对照的30(IQR 20-44)ng/mL(所有p<0.01)。
- 伤后10小时内,灌注血管比例较差者血栓调节蛋白为4.1(IQR 3.4-6.2)ng/mL,微循环血流指数较差者为4.1(IQR 3.4-6.2)ng/mL,均显著高于健康对照的2.9(IQR 2.2-3.4)ng/mL(两者p<0.05)。
证据类型、等级与局限
- 证据类型:预后研究,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为内皮细胞损伤和糖萼脱落与创伤性失血性休克后微循环血流、密度和异质性变差相关。
- 作者指出这些生物标志物和血流参数在床旁的临床效用尚未阐明。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Endothelial cell damage and glycocalyx shedding after trauma can increase the risk of inflammation, coagulopathy, vascular permeability, and death. Bedside sublingual video-microscopy may detect worse flow and perfusion associated with this endotheliopathy. We compared markers of endotheliopathy with physical flow dynamics after traumatic hemorrhagic shock.
METHODS: Sublingual incident dark field video-microscopy was performed at three time points after injury (<10 hours, 10-30 hours, and 30-50 hours). Values for microcirculatory flow index (MFI), Point Of carE Microcirculation assessment (POEM) score, proportion of perfused vessels (PPV), microcirculatory heterogeneity index (MHI), perfused vessel density (PVD), and total vessel density (TVD) were obtained. ELISAs were performed to measure concentrations of thrombomodulin and syndecan-1 as biomarkers of endothelial cell damage and glycocalyx shedding respectively. Flow parameters were dichotomized to above and below average, and biomarkers compared between groups; below average MFI, POEM, PPV, PVD, and TVD, and above average MHI were considered poor microcirculatory flow dynamics.
RESULTS: A total of 155 sublingual video-microscopy clips corresponding to 39 time points from 17 trauma patients were analyzed. Median age was 35 (IQR 25-52); 16/17 were men. Within 10 hours of injury, syndecan-1 concentrations were significantly higher compared to 17 age- and sex-matched healthy controls (30 [IQR 20-44] ng/mL) for worse TVD (78 [IQR 63-417] ng/mL), PVD (156 [IQR 63-590] ng/mL), PPV (249 [IQR 64-578] ng/mL), MFI (249 [IQR 64-578] ng/mL), MHI (45 [IQR] 38-68) ng/mL), and POEM scores (108 [IQR 44-462] ng/mL) (all p < 0.01). Thrombomodulin was also raised within 10 hours of injury when compared to healthy controls (2.9 [IQR 2.2-3.4] ng/mL) for worse PPV (4.1 [IQR 3.4-6.2] ng/mL) and MFI (4.1 [IQR 3.4-6.2] ng/mL) (both p < 0.05).
CONCLUSIONS: Endothelial cell damage and glycocalyx shedding are associated with worse flow, density, and heterogeneity within microvessels after traumatic hemorrhagic shock. The clinical utility of these biomarkers and flow parameters at the bedside are yet to be elucidated.
LEVEL OF EVIDENCE: Prognostic study, level III.
参考来源
- Naumann DN, Hazeldine J, Midwinter MJ, et al. Poor microcirculatory flow dynamics are associated with endothelial cell damage and glycocalyx shedding after traumatic hemorrhagic shock. J Trauma Acute Care Surg. 2018. PMID: 28885470. doi:10.1097/TA.0000000000001695
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。